___

Borgel J, Sanner BM, Bittlinsky A, et al. Obstructive sleep apnea and its therapy influence high-density lipoprotein cholesterol serum levels. Eur Respir J. 2006;27:121-7.

Lowe GD. Fibrinogen measurement to assess the risk of arterial thrombosis in individual patients: not yet. J Thromb Haemost. 2005;3:635‐7.

Naji DH, Tan C, Han F, et al. Significant genetic association of a functional TFPI variant with circulating fibrinogen levels and coronary artery disease. Mol Genet Genomics. 2018;293:119‐28.

Zhang L, Xu C, Liu J, et al. Baseline plasma fibrinogen is associated withhemoglobin A1c and 2-year major adverse cardiovascular events following percutaneous coronary intervention in patients with acute coronary syndrome: a single-centre, prospective cohort study. Cardiovasc Diabetol. 2019;18:52.

Lowe G, Woodward M, Hillis G, et al. Circulating inflammatory markers and the risk of vascular complications and mortality in people with type 2 diabetes and cardiovascular disease or risk factors: the ADVANCE study. Diabetes. 2014;63:1115‐23.

Meade TW, North WR, Chakrabarti R, et al. Haemostatic function and cardiovascular death: early results of a prospective study. Lancet. 1980; 1:1050–4.

Izci B, Ardic S, Firat H, et al. Reliability and validity studies of the Turkish version of the Epworth Sleepiness Scale. Sleep Breath. 2008;12:161-8.

American Academy of Sleep Medicine. International Classification of Sleep Disorders, 3rd Ed. IL: American Academy of Sleep Medicine, 2014.

Javaheri S, Barbe F, Campos-Rodriguez F, et al. Sleep apnea: Types, mechanisms, and clinical cardiovascular consequences. J Am Coll Cardiol. 2017;69:841‐58.

Anker SD, von Haehling S, Germany R. Sleep-disordered breathing and cardiovascular disease. Indian Heart J. 2016;68 Suppl 1: S69‐S76.

Liu W, Yue H, Zhang J, et al. Effects of plasma ghrelin, obestatin, and ghrelin/obestatin ratio on blood pressure circadian rhythms in patients with obstructive sleep apnea syndrome. Chin Med J (Engl). 2014;127:850‐5.

Baguet JP, Hammer L, Levy P, et al. Night-time and diastolic hypertension are common and underestimated conditions in newly diagnosed apneic patients. J Hypertens. 2005;23:521–7.

Li K, Chen Z, Qin Y, et al. MiR-664a-3p expression in patients with obstructive sleep apnea: A potential marker of atherosclerosis. Medicine (Baltimore). 2018;97:e9813.

McArdle N, Riha RL, Vennelle M, et al. Sleep-disordered breathing as a risk factor for cerebrovascular disease: a case-control study in patients with transient ischemic attacks. Stroke. 2003;34:2916-21.

Peled N, Kassirer M, Kramer MR, et al. Increased erythrocyte adhesiveness and aggregation in obstructive sleep apnea syndrome. Thromb Res. 2008;121:631‐6.

Sanders MH, Givelber R. Sleep disordered breathing may not be an independent risk factor for diabetes, but diabetes may contribute to the

Lisabeth LD, Sánchez BN, Lim D, et al. Sleep-disordered breathing and poststroke outcomes. Ann Neurol. 2019;86:241‐250.

Mohammadieh A, Sutherland K, Cistulli PA. Sleep disordered breathing:

Berge T, Lyngbakken MN, Ihle-Hansen H, et al. Prevalence of atrial fibrillation and cardiovascular risk factors in a 63–65-year-old general population cohort: The Akershus Cardiac Examination (ACE) 1950 Study. BMJ Open. 2018;8:e021704.

Basoglu OK, Sarac F, Sarac S, et al. Metabolic syndrome, insulin resistance, fibrinogen, homocysteine, leptin, and C-reactive protein in obese patients with obstructive sleep apnea syndrome. Ann Thorac Med. 2011;6:120‐5.

Turner K, Zambrelli E, Lavolpe S, et al. Obstructive sleep apnea: neurocognitive and behavioral functions before and after treatment. Funct Neurol. 2019;34:71‐8.

Akinci B, Aslan GK, Kiyan E. Sleep quality and quality of life in patients with moderate to very severe chronic obstructive pulmonary disease. Clin Respir J. 2018;12:1739‐46.

Zhang L, Meng R, Shang S, et al. Obstructive sleep apnea before ischemic stroke: Clinical relevance to infarction volume and neurological recovery. J Stroke Cerebrovasc Dis. 2019;28:2132‐9.

Asada Y, Yamashita A, Sato Y, et al. Thrombus formation and propagation in the onset of cardiovascular events. J Atheroscler Thromb. 2018;25:653‐64.

Koupenova M, Kehrel BE, Corkrey HA, et al. Thrombosis and platelets: an update. Eur Heart J. 2017;38:785‐91.

Yu L, Li X, Huang B, et al. Atrial fibrillation in acute obstructive sleep apnea: Autonomic nervous mechanism and modulation. J Am Heart Assoc. 2017;6:e006264.

Archontogeorgis K, Voulgaris A, Papanas N, et al. Mean Platelet Volume and Platelet Distribution Width in Patients with Obstructive Sleep Apnea Syndrome and Concurrent Chronic Obstructive Pulmonary Disease. Clin Appl Thromb Hemost. 2018;24:1216‐22.

Zhang L, Meng R, Shang S, et al. Obstructive sleep apnea before ischemic stroke: Clinical relevance to infarction volume and neurological recovery. J Stroke Cerebrovasc Dis. 2019;28:2132‐9.

Yang G, Cun L, Ma Y, et al. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2015;29:1710‐2.

Wessendorf TE, Thilmann AF, Wang YM, et al. Fibrinogen levels and obstructive sleep apnea in ischemic stroke. Am J Respir Crit Care Med. 2000;162:2039–42.

Nobili L, Schiavi G, Bozano E, et al. Morning increase of whole blood viscosity in obstructive sleep apnea syndrome. Clin Hemorheol Microcirc. 2000;22:21–7.

Dediu GN, Diaconu CC, Dumitrache Rujinski S, et al. May inflammatory markers be used for monitoring the continuous positive airway pressure effect in patients with obstructive sleep apnea and arrhythmias? Med Hypotheses. 2018;115:81‐6.

Toraldo DM, De Benedetto M, Scoditti E, et al. Obstructive sleep apnea syndrome: coagulation anomalies and treatment with continuous positive airway pressure. Sleep Breath. 2016;20:457‐65.

Kaditis AG, Alexopoulos EI, Kalampouka E, et al. Morning levels of fibrinogen in children with sleep-disordered breathing. Eur Respir J. 2004;24:790-7.

Xiao Y, Yang LR, Zhu GF, et al. Zhonghua Yi Xue Za Zhi. 2019;99:739‐43.